Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 364

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 364
---
3,135 |   |     |     (7,221 | ) |     |      2,519 |   |
| Cash and cash equivalents at beginning of year         |     |      |     |      2,836 |   |     |     10,057 |   |     |      7,546 |   |
| Exchange (losses)/gains on cash and cash equivalents   |     |      |     |          – |   |     |          – |   |     |         (8 | ) |
| Cash and cash equivalents at end of year               |     |   14 |     |      5,971 |   |     |      2,836 |   |     |     10,057 |   |

The notes form an integral
part of these consolidated financial statements.

| F-27 |

Consolidated
statements of changes in equity

For the year ended 31 December

|                                                       |     |  Note |     | Share capital £’000 |     | Share premium £’000 |   |     |        Merger 
 reserve £’000 |     | Warrant 
 reserve 
   £’000 |     | Accumulated deficit £’000 |   |     | Total equity £’000 |   |
| At 1 January 2023                                     |     |       |     |               1,108 |     |              83,667 |   |     |        53,003 |     |     720 |     |                  (135,336 | ) |     |              3,162 |   |
| Loss for the year                                     |     |       |     |                   – |     |                   – |   |     |             – |     |       – |     |                    (7,079 | ) |     |             (7,079 | ) |
| Total comprehensive loss                              |     |       |     |                   – |     |                   – |   |     |             – |     |       – |     |                    (7,079 | ) |     |             (7,079 | ) |
| Transactions with owners                              |     |       |     |                     |     |                     |   |     |               |     |         |     |                           |   |     |                    |   |
| Shares issued on 15 February 2023                     |     | 14,21 |     |               1,956 |     |               3,013 |